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Overexpression of hepatocyte nuclear factor (Foxa-2), a master regulator significantly enhances the hepatic 
differentiation by triggering targeted liver-specific gene expression for liver development. We investigated the function of 
key regulators that facilitate hepatic differentiation. The functional hepatocyte was determined by observing morphological 
changes, expression of liver specific markers through immunocytochemical analysis, qRT-PCR, Western Blot and specific 
liver function assays. Our study confirmed that induction of functional hepatocyte shows typical epithelial morphology, 
express hepatic genes and acquire hepatocyte functions. Notably, these cells expressed the markers of mature hepatocytes, 
including albumin, tyrosine aminotransferase, cytokeratin, Cyp7A1 and hepatic transcription factors. Furthermore, these 
cells exhibited hepatic functions in vitro, including glycogen storage, albumin production, urea secretion and functional 
assessment of hepatocytes. We have developed a robust and efficient method to differentiate mesenchymal stem cells into 
induced functional hepatocytes, which exhibits characteristics of mouse hepatocytes. Apparently, induction of functional 
hepatocytes will pave a better cellular therapy or effective cell source within a short timeline to facilitate the development of 
hepatocytes for future clinical applications of regenerative medicine. 
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Fulminant hepatic failure (FHF) is the major 
outcome from of a primary liver insult, which leads 
to failure of multiple organs with innumerable 
complications. The death from advanced FHF is 
high and the accessibility of donor livers for 
transplantation is an alternative way to rescue FHF 
patients. However, the limited availability of 
donors resulted in the burgeoning interest in 
developing stem cell therapy as alternatives to liver 
regeneration
1,2
. Stem cells presented in all organs 
play a very critical role in maintaining the tissue 
homeostasis. Normal physiological surroundings, 
hepatic progenitors reveal a low proliferative 
potential and location of stem cell niche inside the 
intrahepatic biliary tree maintaining the liver 
specific stem cells under quiescent state. Upon liver 
injury, the stimulated stem cell niche augments bi-
potential transient cells to differentiate into mature 
bile duct cells and hepatocytes
3
. Bone marrow and 
or blood derived mesenchymal stem cells have also 
been considered as an alternative cell source apart 
from tissue derived stem cells that are able to 
differentiate into functional hepatocytes
4
. More 
reports are available suggesting embryonic stem 
cells (ESCs) and umbilical cord stem cells (UCSTs) 
have the potential to differentiate into mature 
hepatocytes due to its pluripotent nature. Moreover, 
its therapeutic practice is limited due to responses 






The two winged helix transcription factors belongs 
to the Foxa family members includes HNF 3α, β, and 
γ (hepatocyte nuclear factor) are known as Foxa 1, 
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Foxa 2, and Foxa 3, respectively, considered as key 
transcription factors in regulating the proper 
formation of foregut and hindgut during embryonic 
development
6
. Regulation of hepatogenesis and 
maintenance of hepatic homeostasis, a Foxa family 
member plays a leading role right from 
embryogenesis to adult liver functioning. Foxa 
proteins were also shown to regulate chromatin 
remodeling via nucleosome relaxation which is very 
crucial in priming hepatogenesis before the actual 
transcription of hepatic genes begins
7
. Mouse 
embryonic studies indicated the potential role of Foxa 
proteins as pioneer factors in determining definitive 




Foxa-2 is a liver-enriched nuclear transcription 
factor that plays a key function in the early 
development of the endoderm which is the precursor 
to form the liver. During embryonic liver 
development process, the establishment of defined 
foregut endoderm from cardiac mesoderm signals and 
stimulation of liver-specific gene expression were the 
two major events that regulate hepatogenesis. These 
transcription factors showed a significant role in 
creating the endodermal domain that finally 
contributes for liver development. HNF-4α is 
necessary for Foxa-2 expression and endoderm 
development that responds to the fibroblast growth 
factors (FGF) signal, via foregut endoderm 
commitment upon receiving the signal. Also, FGFs 
from the cardiac mesoderm were found to stimulate 
liver markers in the ventral foregut endoderm, 
resulting in outgrowth of the endoderm and hepatic 
differentiation
9
. It has been demonstrated that Foxa 1 
and Foxa 2 deficient endoderm failed to react to FGF2 
signal that made it further inefficient in activating the 




The chromatin structure of the albumin enhancer 
region during hepatogenesis, showed GATA and Foxa 
factors bound to the enhancer of gut endoderm prior 
to the albumin gene initiation
11-13
. These findings 
suggested that GATA and FOXA as genetic activators 
of hepatic differentiation
14,15
. Several data demonstrated 
that binding of Foxa-2 and GATA protein could 
facilitate the interaction with CBP (CREB binding 
protein) which enhances transcriptional activation
16
.  
It is also known that Foxa proteins binds DNA-
nucleosome core region and resulted in the 
decompacting of the chromatin, which further 




In vitro hepatic differentiation can also be 
stimulated from stem cells by means of inducers 
including chemical compounds, growth factors and 
cytokines, but limited to low differentiation 
efficiencies that hampers isolating functional 
hepatocytes. Overexpression of nuclear factors can 
directly differentiate the stem cells phenotypically, 




In the present study, we tried to evaluate the 
effectiveness of overexpression of Foxa-2 on hepatic 
trans-differentiation potential of bone marrow MSCs.  
 
Materials and Methods 
 
Animals 
Normal inbred 6 week old BALB/c mice were 
procured from King’s Institute, Chennai, an enlisted 
supplier of CPCSEA (Committee for the Purpose of 
Control and Supervision of Experiments on Animal), 
India. The animals were provided with pellet diet and 
water ad libitum and were sacrificed on the same day 
of purchase to isolate bone marrow Mesenchymal 
Stem Cells (MSC’s). All procedures used in the study 
were done by following the guidelines of the 
CPCSEA, (Government of India) and approved by 
Indian Institute of Technology Madras, Institutional 
Ethics Committee (Ref. No. IEC/2010/08/RSV-4/03). 
 
MSC isolation 
Bone marrow derived MSCs (BM-MSCs) were 
isolated according to the method followed by 
Soleimani & Nadri
20
. The isolated population were 
cultured in DMEM/F12 medium supplemented with 
20% FBS, 100 µg/mL penicillin and streptomycin at 
37°C in humidified incubator with 5% CO2. After 2 
days, BM-MSCs were washed with medium to 
remove the non-adherent floating cells. The culture 
was maintained until it reaches confluence of 80% by 
changing the medium every 3 days. Briefly, on 
reaching confluence the populations were trypsinized 
and maintained till 4 to 5 passages. Further, all assays 
and studies were done between 3 to 15 passages. 
 
Characterization of BM-MSCs and its multilineage differentiation 
Characterization of BM-MSCs at passage 3 was 
done by immunocytochemistry. Cells were 
trypsinized and washed twice with Dulbecco's 
phosphate buffered saline (DPBSA). Further, the 
pellet was then fixed with 4% paraformaldehyde for 
20 min and washed with DPBSA. Then the cells were 
permeabilized with 0.25% Triton X for 20 min and 
washed with DPBSA twice. The cells were blocked 




with 5% FBS for 90 min and washed with DPBSA 
twice. Cells were stained for the following 
monoclonal antibodies CD29, CD44, CD90, CD 105, 
Sca-I, CD 34 and CD45 for 16 h at 4°C. After 
incubation, the cells were washed with DPBSA thrice 
and the appropriate secondary antibody conjugated 
with PE and FITC was added along with the nuclear 
stain Hoechst for 2 h in RT (28°C) in dark. The cells 
were washed with DPBSA twice and observed under 
Fluorescence microscope Nikon Ti Eclipse, Japan. 
 
Construction of PCDNA3.1/Foxa-2 recombinant clone selection 
The CMV-Foxa2 (HNF-3β) expression vector 
containing the full-length rat cDNA (1.6-kb EcoRI 
fragment) and two truncated Foxa2 plasmids 
expressed from the cytomegalovirus promoter. The 
upstream primer was 5′-CGGAATTCTACTCTTCCG 
TGAGCAAC-3′, and the downstream primer was  
5′-CGCGGATCCGGACGAGTTCATAATAG-3′. The 
PCR product was cloned into pcDNA 3.1 Myc 
(procured from Prof. Andrew Russo, University of 
Iowa), resulting in the generation of 
PCDNA3.1/FOXa-2. The Foxa-2 fragment was 
confirmed by digesting with Xho I and Hind III 
restriction sites and sequenced. After passage 4, the 
BM-MSCs were transfected with the recombinant 
plasmid using Lipofectamine 2000 (Invitrogen). The 
target gene overexpression was confirmed by  
RT-PCR and immunofluorescence. The transfected 
BM-MSCs were cultured in medium with G418 
(neomycin) (with increasing concentration) for the 
selection of resistant clones. Further, the selected 
clones were used for the differentiation studies.  
 







 passages were harvested 
for assessing osteogenic lineage differentiation and 
mineralization as per the method of von Kossa and 









 passages were 
harvested, adipogenic lineage differentiation and lipid 
accumulation was assessed biochemically by Oil Red-





BM-MSCs of passage 3 were cultured on type-I 
collagen coated 6-well plates till 80% confluence in 
DMEM/F12 (20% FBS + antibiotics). Induction of 
functional hepatic transdifferentiation was carried out 
according to Lee et al.
22





) were subjected 
to serum deprived condition with 10 ng/mL fibroblast 
growth factor (bFGF) and 20 ng/mL epidermal 
growth factor-4b (bEGF) for 2 days in DMDM 
medium. The medium was replenished after 48 h, by 
hepatocyte differentiation medium (DMEM 
containing well defined growth factor cocktail of 10 
ng/mL bFGF + 20 ng/mL HGF + 0.61 g/L 
nicotinamide) for six days. The medium was replaced 
with maturation medium [DMEM containing well 
defined growth factor cocktail of dexamethasone (1.0 
μM/l) + oncostatin M (20 ng/mL) + ITS (Insulin, 
Transferrin, selenium, linoleic acid) (50 mg/mL)]. 
Cultures were maintained for 28 days, during which 
maturation medium was changed once every four 
days
7,22
. Induction of functional hepatic differentiation 
was carried out by considering BM-MSCs with the 
following groups: Gr. I: Normal BM-MSCs 
maintained in DMEM/F12 (20% FBS) throughout the 
studies, Normal BM-MSCs as a negative control 
group (BM-MSCs); Gr. II: Normal BM-MSCs 
maintained in hepatogenic differentiation systems (D-
MSCs); and Gr. III: Foxa-2 transfected BM-MSCs 
maintained in hepatogenic differentiation systems 
(Foxa-2-MSCs).  
 
Characterization of Foxa-2 Induced BM-MSC-derived 
functional hepatocytes 
 
Examining the morphological changes 
During hepatogenic differentiation of BM-MSCs 
differences in morphology of cell differentiation in all 
groups were examined at different time intervals by 
phase contrast microscopy (Olympus, CX-41).  
 
Evaluating the functional characteristics of hepatocyte 
The expression of functional specific markers of 
hepatocytes (Albumin (Alb), Cytokeratin 18 (CK18), 
Cytokeratin 19 (CK19) and Foxa-2) was investigated 
for all groups (induced and uninduced) after 3 weeks 
of induction according to Dhanasekaran et al.
3
 and 
observed by fluorescence microscope (Nikon Tie, 
Japan). 
 
Expression of functional specific hepatic genes 
Total RNA was extracted by Trizol reagent (Sigma 
Aldrich, USA) from all the induced and uninduced 
groups (BM-MSCs, D-MSCs and Foxa-2-MSCs) 
according to the manufacturer's instructions The 
cDNA templates were attained by reverse 
transcription of total RNA using MMLV-RT (Thermo 
scientific, USA) and oligo-dT primers (NEB, USA). 
RT- PCR and quantitative real-time PCR (qRT-PCR) 
with primers designed specific for functional 




hepatocytes listed in Table 1 using Applied 
Biosystems SYBR Select Master mix (Applied 
Biosystems 7500 Real-Time PCR Systems, Life 
Technologies, USA). Relative mRNA quantification 
by normalization to β-actin housekeeping gene and 
the fold change was then calculated by CT (2-
ΔΔCT
) 
method. The analysis was performed in triplicate for 
statistical validation. 
 
Functional Assessment of Foxa-2 Induced BM-MSC-derived 
hepatocytes  
Liver functional activities were determined to 
validate the functionality of Foxa-2 induced BM-
MSC-derived hepatocytes.  
 
Assessment of glycogen storage by PAS 
The insoluble stored glycogen was assessed in 
hepatogenic differentiated cells by periodic acid 
Schiff’s staining (PAS) for all groups (induced and 
uninduced) after 3 weeks of induction according to 
Dhanasekaran et al.
7 
and visualized under phase 
contrast microscope.  
 
Albumin and Urea Secretion 
The albumin secretion was determined in the 
supernatant of the induced and un-induced (BM-
MSCs, D- MSCs and Foxa-2-MSCs) cells at different 
time periods (0, 6, 12, 24 and 28 days) using a mouse 
ALB ELISA quantitation kit (Bethyl, USA) according 
to the manufacturer’s instructions. Urea concentration 
was assessed in induced and uninduced (BM-MSCs, 
D-MSCs and Foxa-2-MSCs) cells at various time 
intervals using urea assay kit (Sigma) were measured 
as per manufacturer’s instruction. The data were 
normalized based on cells (10
5
 live cells) which is 
collected from the conditioned media for the assays.  
 
Cellular uptake and release of ICG 
Assessment of liver function was performed by 
examining the uptake and release of indocyanine 
green (ICG) dye assay was performed in induced and 
un-induced (BM-MSCs, D-MSCs and Foxa-2-MSCs) 
as per Lee et al.
22
. The cells were photographed to 
ensure the release of ICG under inverted light 
microscope. 
 
Evaluating the functional hepatic protein expression  
Expressions of the functional specific hepatic 
markers (Albumin, CK18, CK19 and Foxa-2) were 
investigated for all groups (induced and uninduced) 
after 3 weeks of induction. The hepatic protein 
expression was detected using enriched 
chemiluminescence Pierce ECL Plus western blotting 
detection reagents (Pierce, USA) according to the 
manufacturer’s instruction.  
 
Statistical analysis 
All data presented in this study as the mean ± SD 
(standard deviation). One-way repeated measures 
analysis of variance (ANOVA) was used to analyze 
group differences. P <0.05 was considered as 
statistically significant between the groups.  
 
Results and Discussion 
 
Isolation and Characterization of BM-MSCs 
The heterogeneous populations were found to be 
plastic adherent and showed a typical fibroblastic 
morphology under phase contrast microscope. Immuno-
cytochemistry was done to address the surface marker 
profile of isolated cells. MSCs were found to express 
markers like CD29, CD90, CD44 and Sca I [Fig 1A(i-iv)], 
 
Table 1 — Primers used for RT-PCR and qRT-PCR 
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and was negative for CD34 and CD45 [Fig.1 (v and vi)]. 
BM-MSCs were subjected to adipogenic and 
osteogenic differentiation using defined chemical 
cues. Alizarin-red staining used to confirm osteogenic 
lineage showed calcium mineralization in differentiated 
BM-MSCs. Fig. 1B(i) shows un-induced control  
BM-MSCs with their normal morphology stained 
negative, Fig. 1B(ii) is stained positive for 
mineralization by Oil Red O stain and Fig. 1B(iii) and 
depicts the mineralized matrices by von Kossa assay. 
Accumulation of intracellular lipid droplets was 
observed that indicates the adipogenic lineage as seen 
by the oil aggregation in differentiated BM-MSCs. 
Fig. 1C(i) shows uninduced control BM-MSCs with 
normal morphology stained negatively with alizarin 
red, Fig. 1C(ii) indicates BM-MSCs with oil droplets 
stained positively by Oil Red O assay and Fig. 1C(iii) 
stained positive for alizarin red. Scale bars, 100 µm. 
(Original magnification, X100). 
 
Stage-specific Foxa-2-MSCs selectively promotes hepatic 
differentiation 
D-MSCs and Foxa-2-MSCs were induced for 
hepatogenic differentiation. Upon differentiation, the 
phenotype of mesenchymal stem cell changes from its 
inherent fibroblastic spindle to polygonal shape 
drastically within 28 days of hepatogenic induction, as 
observed under phase contrast microscope (Fig. 2). In 
the absence of growth factors, no changes in the cellular 
morphology of BM-MSCs (Group I) [Fig. 2A (i-iv)] 
was observed, whereas the addition of growth factors 
produced morphological changes resembling mature 
cells depends upon the time period. Compared with 
control, morphological changes were more prominent 
and homogenous in Foxa-2 transfected cells that were 
hepatocyte-like cells. In group II D-MSCs with 
growth factors showed a large number of a 
heterogeneous population consisting of hepatoblasts 




Fig. 1 — Characterization of bone marrow  derived MSCs. (BM-MSCs) (A) Immunocytochemistry shows that BM-MSCs is positive for 
the expression of (i) CD29, (ii) CD44, (iii) CD90 and (iv) Sca 1, but negative for the expression of (v) CD34 and (vi) CD45; (B) MSCs 
are induced to differentiate into osteoblasts, (i) Control BM-MSCs (un-induced) with their normal morphology stained negative, (ii) 
positive stain for mineralization by Oil Red O stain (iii) and positive stain for mineralized matrices by von Kossa assay; and (C) Under 
adipogenic conditions, MSCs accumulate lipid vacuoles, (i) Control BM-MSCs (un-induced) with normal morphology stained negative 
with alizarin red , (ii) positive strain for oil droplets by Oil Red O assay (iii) and positive stain for oil droplets by alizarin red. [Scale bars, 
100 µm. (Original magnification, X100)] 
 




hepatocyte-like cells [day 28, Fig 2B (i-iv)]. When 
compared, these cells with Foxa-2-MSCs showed 
morphological changes that highly resemble 
heterogeneous population consisting of hepatoblasts 
(day 12) and mature hepatocyte-like cells (day 20, 28) 
were observed [Fig 2C (i-iv)]. This enhanced effect of 
hepatocyte differentiation might be due Foxa-2 over 
expression which selectively promotes induction of 
functional hepatic differentiation and represses biliary 
differentiation. 
 
Induction of functional hepatocyte markers expression by 
Foxa-2  
To confirm induction of functional hepatocyte 
differentiation, we evaluated the functional efficacy of 
hepatocyte via immunocytochemical staining for liver 
markers that includes; Alb, CK18, CK19 and Foxa-2 
(Fig. 3A). Our analyses for albumin secretion 
indicated rather than D-MSCs, the Foxa-2-MSCs had 
higher efficiency to secrete albumin at day 28 while 
other markers were stained diffusely in cytoplasm; 
CK19 was barely detectable (Fig. 3A), but the 
expression of CK18 was increased in Foxa-2-MSCs 
than D-MSCs. Foxa-2 expression was observed more 
in Foxa-2-MSCs and localized in the nucleus (Fig. 3A). 
However, hepatic marker expression in D-MSCs was 
negligible. BM-MSCs cells were negative for the 
hepatocyte marker profiles.  
 
Liver Function Activity of Foxa-2-MSC Induced Functional 
Hepatocytes 
Albumin secretion was negligible at day 6 and 12, 
which continuously increased significantly (P <0.05) 
and reached its maximal values at day 28 in Foxa-2-
MSCs induction group compared to D-MSCs 
induction group and control BM-MSCs (Fig. 3B). 
Urea production also reveals that Foxa-2-MSCs 
induced hepatocytes had higher levels on day 28 
compared to D-MSCs. In comparison with Foxa-2-
MSCs, urea production was significantly decreased  
(P <0.05) in D-MSCs. Urea production in BM-MSCs 
was absent (Fig.3C). Urea secretion and albumin 
production were normalized for 10
5
 cells per well in 
all groups (Fig. 3 C and B). We measured the ability 
of stored glycogen as the functional activity of 
differentiated hepatocytes, a specific activity of 
hepatic cells by PAS staining. Microscopic analysis 
showed that the Foxa-2 induced functional hepatic 
cells revealed profound levels of glycogen storage 
(pink) in comparison with D-MSCs and negative 
controls (BM-MSCs) (Fig. 4). The PAS staining was 




Fig. 2 — Phase contrast micrographs showing in vitro morphological changes observed during hepatic trans-differentiation of BM-MSCs 
with and without foxa-2 transfection for different days (2, 12, 20 and 28 days). (A) Control BM-MSCs as a negative control shows the 
normal morphology; (B) MSCs derived hepatocytes generated by hepatogenic induction without Foxa-2 transfection (D-MSCs) (group 
II)) with different days; and (C) Foxa-2 transfected MSCs induced functional hepatocytes generated by hepatogenic induction for 
different days. [Scale bars, 100 µm. (Original magnification, X100)] 
 




stored glycogen was measured only in the cytoplasm. 
This finding suggested that the stored glycogen 
detected in the Foxa-2-MSCs were highly positive for 
glycogen than in D-MSCs. The cytoplasmic glycogen 
storage, cuboidal morphology, prominent nucleoli, 
and nuclear-to-cytoplasmic ratio highly specific  
to functional hepatocytes were acquired more 
prominently in Foxa-2 overexpressed group (Foxa-2-
MSCs) group III compared with other groups. 
Similarly, the microscopic observation of induced 
functional hepatocytes from Foxa-2-MSCs showed 
higher levels of ICG uptake and rapid release of ICG 
when compared to D-MSCs cultures, while control 
BM-MSCs cultures completely excluded the anionic 
solution (Fig. 4 ICG uptake and release).  
 
RT-qPCR and RT-PCR analysis of functional hepatic 
markers expression by Foxa-2 
Relative quantification of functional hepatic 
specific marker genes (Albumin, CK8, CK18, CK19, 
p450 (Cyp)3a11, Transthyretin, AAT, TAT, AFP, 
PXMP1-L, PEPCK, and γ-GT) by qRT-PCR revealed 
their upregulation in Foxa-2-MSCs induced hepato-
cytes group as well as D-MSCs group (Fig 5 A-F), 
with no expression observed in untreated BM-MSCs 
group. Compared to D-MSCs, the Foxa-2-MSCs 
exhibited considerably enhanced expression of Foxa 1 
and HNF1α (Fig. 5D), integral members of the 
combinatorial hepatic regulatory network that 
regulates hepatic transcription as well as upregulated 




Fig. 3 — Immunofluorescence analysis, albumin and urea secretion of specific hepatic markers. (A) Immunofluorescence micrographs 
(merged) showing positive expression of hepatocyte specific markers, albumin (Alexafluor 488: green colour), CK-18 (Alexa Fluor 594: 
red colour), CK-19 (Alexa Fluor 594: red colour) and Foxa2 (Alexa Fluor 594: red colour) in BM-MSCs derived hepatocyte-like 
colonies with and without Foxa-2 transfection after 28 days of differentiation and negative expression in undifferentiated BM-MSCs. 
[Nuclei were stained with DAPI (blue colour). (Original magnifications × 100) (Scale bars  = 100 μM)]; (B) Secretion of albumin in a 
time-dependent manner. [* denotes the significant increase (*P <0.05) in albumin secretion in Foxa-2 transfected MSCs compared to D-
MSCs (group II) cells. # denotes the significant increase (*P <0.05) in albumin secretion in group II and group III cells compared to 
normal MSCs]; and (C) Secretion of urea in a time-dependent manner. [*denotes the significant increase (*P <0.05) in urea secretion in 
Foxa-2-MSCs transfected cells compared to D-MSCs treated cells. # denotes the significant increase (*P <0.05) in urea secretion in both 
groups compared to normal BM-MSCs untreated] 
 







Fig. 4 — Light micrographs showing glycogen storage and ICG uptake and release during hepatic trans-differentiation of MSCs with and 
without foxa-2 transfection. (A) PAS staining for glycogen storage showed differentiated and undifferentiated cells; and (B) Uptake and release 




Fig. 5 — Quantitative real time PCR, RT-PCR and Western Blot expression of hepatocyte specific genes. (A-F) shows qRT-PCR of hepatocyte 
specific genes. [Positive expression of ALB, AFP, CK19, CK18, CK 8, HNF-1α, HNF-1β, Foxa-2a,, HNF-4α, HNF-6, p450 1, Foxa -2b, γ-GT 
and AAT were observed in both D-MSCs and Foxa-2-MSCs induction group, compared to untreated BM-MSCs. There was a significant 
difference in expression between D-MSCs and Foxa-2-MSCs induction group (**P  <0.05), but it was significantly lesser compared to HepG2 
(*P <0.05). Negative expression of AFP, c/EBPA and c/EBPB were observed in both (D-MSCs and Foxa-2-MSCs), but it was significantly 
higher compared to HepG2 (*P <0.05). #P <0.05 denotes the significant difference between Foxa-2-MSCs and HepG2. The expressions of genes 
were normalized to β-actin and mRNA of untreated BM-MSCs was used as calibrator]; (G) Gel picture showing of hepatic specific genes which 
is compared with HepG2 as positive control. [Lane-1: Normal BM-MSCs (Control), Lane-2: D-MSCs, Lane-3: Foxa-2-MSCs and Lane-4: 
HepG2]; and (H) Expression of hepatocyte-specific proteins such as Albumin, CK18, CK19, HNF-3β with β-actin (positive control) by Western 
Blot analysis. [Normal BM-MSCs, D-MSCs induced hepatocytes, Foxa-2-MSCs induced functional hepatocytes and HepG2] 
 




was a significant difference in expression between the 
two D-MSCs and Foxa-2-MSCs induction group  
(**P <0.05), but it was significantly lesser compared 
to HepG2 (*P <0.05). Negative expression of AFP, 
c/EBPA and c/EBPB were observed in both (D-MSCs 
and Foxa-2-MSCs), but it was significantly higher 
compared to HepG2 (*P <0.05). 
#
P <0.05 denotes the 
significant difference between Foxa-2-MSCs and 
HepG2. The expression of genes was normalized to  
β-actin and mRNA of untreated BM-MSCs was used 
as calibrator.  
 
Induced functional hepatocyte mRNA expression 
of Albumin, CK8, CK18, CK19, p450 (Cyp)3a11, 
Transthyretin, AAT, TAT, AFP, PXMP1-L, PEPCK, 
and γ-GT were augmented in Foxa-2-MSCs when 
compared with D-MSCs which reflects the 
progression of mature functional hepatocytes. Hepatic 
transcription factor mRNA expression (HNF-1α, 
HNF-1β, HNF-3α, HNF-3β, HNF-4α, HNF-6) were 
increased in Foxa-2-MSCs induced hepatocytes when 
compared with D-MSCs hepatocyte which efficiently 
promotes hepatic maturation.  
Additionally, functional hepatocyte specific 
markers includes albumin, CK18, CK19 and Foxa-2 
level was found to be upregulated in Foxa-2-MSCs 
induced hepatocytes when compared to D-MSCs 
hepatocyte in immunoblot assay with HepG2 cell line 
as positive control (Fig. 5H).  
 
In recent research study using rat models of 
transplantation of primary hepatocyte revealed 
efficacious donor chimerism that rescued animals 
from severe hepatic failure
23
. Thus, hepatocyte 
transplantation has gained major attention in liver 
regeneration therapies and also emerged as a potential 
remedy to solve the problem of treating end stage 
liver diseases. We endeavored to analyze the role of 
liver specific transcription factor Foxa-2 in inducing 
or enhancing hepatogenesis in BM-MSCs. Many 
reports were available regarding the multipotential 
differentiation ability of BM-MSCs, hence they are 
considered as the better source for transplantation 
without the risk of immune rejection
24,25
. Currently, 
the protocol uses various growth factors and cytokines 
for inducing hepatogenesis in MSCs. However, the 
efficacy of MSCs differentiating into hepatocytes 
needs improvement to derive the functional cell type 
of clinical importance. It has been reported that 
epidermal growth factor (EGF) induced hepatogenesis 
by triggering proliferation in hepatocytes which 
resulted in re-establishing the liver homeostasis 
following liver injury
26
. Early investigation 
demonstrated that bFGFs play a key function in 
endoderm development of liver in embryogenesis 
which is secreted by cardiac mesoderm. It also 
demonstrated that the Foxa-2 expression is a major 
key factor for the development of a definitive 
endoderm to respond to bFGF signals for 
hepatogenesis
22
. HGF possesses multipotential 
functions reported as enhancing the hepatocyte 
proliferation and morphogenesis. Oncostastin M 
(OSM) is a cytokine for promoting hepatic 
maturation. Finally OSM and HGF are involved in 
later stages of hepatogenesis along with insulin and 
dexamethasone at the latter stage of in vitro 
differentiation
27
. However, still optimizing the culture 
conditions for deriving functional hepatocyte from the 
adult source is still not fully established. For 
achieving success in optimizing the cultural protocol 
for deriving functional hepatocytes, it is necessary to 
understand the specific signaling biology in 
hepatogenesis.  
 
Earlier studies suggested that, the establishment of 
defined foregut endoderm and induction of functional 
hepatic gene expression were the two important 
events during embryonic hepatogenesis. Foxa-2 and 
Gata-4 bind with hepatic enhancers and alter them as 
possessing effective potential to be expressed 
following induction. These transcription factors have 
a capacity to identify their specific binding sites in the 
chromatin
27,28
. Thus, among the hepatic transcription 
factors presented in the definitive endoderm, Foxa-2 
and Gata 4 act as mediators of competence in the 
foregut endoderm 
14,15
, and both of these factors are 
important for the induction and maintenance of 
hepatic gene expression
29
. Henceforth, in all the 
earlier reports of developmental embryogenesis it was 
clearly proposed that Foxa-2 plays an important 
function in inducing hepatogenesis and maintaining 
the expression of functional hepatocyte genes to carry 
over its function. Current study focused to optimize 
the method of deriving functional hepatocytes via 
overexpressing the liver enriched transcription factor 
Foxa-2 (HNF3-β). This study utilizes various liver 
specific metabolic function activities to critically 
evaluate the degree of differentiation. 
 
In our study, we overexpressed Foxa-2 followed by 
culturing in growth factor defined media for four 
weeks and the results were compared with D-MSCs. 




It was observed the cellular phenotype derived from 
Foxa-2-MSCs induced hepatocytes were 
homogenously polygonal in shape when compared 
with D-MSCs. However, the efficacy of hepato-
genesis was further assessed by screening for the 
stable expression of liver specific genes. Hepatic and 
endodermal specific markers includes HNF-3β, HNF-
4α, HNF-1α, HNF-1β, HNF-3α, HNF-6, cytokeratins 
(CK-8, CK-18, and CK-19), transthyretin (TTR), α-feto 
protein (AFP), α-1-antitrypsin (AAT), albumin, 
tyrosine aminotransferase (TAT), PXMP1-L, phosphor-
enol pyruvate carboxy kinase (PEPCK) and cytochrome 
P450 subunit 3a11 (Cyp3a11) have been determined 
by semi-quantitative RT-PCR analysis in D-MSCs 
and Foxa-2-MSCs (Fig. 5A-G). qRT PCR data clearly 
validated the expression profiles of liver specific 
genes between two groups. As expected there was two 
to five fold increase in the expression of genes such as 
PEPCK, Cyp P450 3a11, PXMP-1L, Foxa-2, 
Albumin, alpha fetoprotein, TAT, CK-19, CK-8, γGT, 
Fox2b respectively. Very little fold change of 0.5 was 
observed in the case of α-1 antitrypsin, CK 18, HNF-
1α, HNF4 and HNF6. These HNFs transcription 
factors were considered as major transcription factors 
in regulating hepatogenesis and in our study, we 
showed significant changes in Foxa-2-MSCs when 
compared with D-MSCs differentiation
30
. The 
functional expression of CK19 and CK8 was 
significantly enhanced in Foxa-2-MSCs induced 
group compared with the D-MSCs group. CK8, 
CK18, and CK19 are specific cyto-skeletal proteins of 
hepatocytes
31,32
 which maintain the morphology of 
hepatocytes while being expressed in fetal liver 
differentiation. AAT and TTR representing 
endodermal differentiation have been reported to be 




Our study of over expressing Foxa-2 has significantly 
increased the expression of AFP which is a known 
endodermal early fetal hepatic differentiation marker 
and ALB is a functional hepatocyte marker most 
abundantly synthesized by mature hepatocytes
34,35
. 
TAT and PEPCK were considered as hepatocyte 
specific enzyme marker for pre-natal or post-natal 
functional hepatocyte differentiations and represent a 
major function of the liver
36-38
. Detectable urea 
secretions were found throughout the 28 day culture 
period and were higher in Foxa-2-MSCs induced 
group. Functionally, the Foxa-2-MSCs induced group 
was found to store glycogen mimicking the in vivo 
characteristics. ICG uptake and release assay suggested 
that Foxa-2-MSCs induced groups were able to retain 
more concentration of ICG followed by its release 
after culturing in the normal media conditions. 
Cytochrome P450 (Cyp) 3a11 protein encoding 
CYP3A11 gene expressed in the liver which is the 
main detoxifying protein reported to be expressed in 
embryoid bodies in vitro differentiation of ESCs into 
hepatocytes
39,40
. In our study, considerable expression 
of Cytochrome P450 3a11 were found in significant 
levels as compared to D-MSCs. 
 
Conclusion 
It has been correlated widely that Foxa proteins play a 
significant role in in vivo hepatogenesis. By over-
expressing lineage specific transcription factors in non-
hepatic source we could achieve functional hepatocytes 
and this study endeavoured to interpret the role of Foxa-
2 in in vitro hepatogenesis. Findings of this study 
suggest that BM-MSCs can trans-differentiate towards 
functional hepatocytes in vitro using overexpression of 
foxa-2. We found Foxa-2 over-expression system 
induces better hepatocyte differentiation resulted in the 
significant increase in expression levels of functional 
hepatocyte genes and proteins to carry over liver specific 
functions like production of albumin, urea secretion and 
storage of glycogen. These foxa-2-MSCs derived 
hepatogenesis, might be clinically relevant for 
autologous cellular therapy and also for in vitro 
preclinical toxicity studies.  
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